ABSTRACT

COVID-19 Vaccine Cross-Border Liability and Compensation [video]   [open html - 0B]

From the Video Description: "The first doses of newly approved vaccines for coronavirus disease 2019 (COVID-19) are slowly rolling out to the public, but manufacturer concern about liability for potential side effects could reduce availability in some countries. In addition, the lack of an effective compensation system raises fairness concerns for those who might suffer adverse reactions, and it could discourage people from rolling up their sleeves for the greater good. The RAND Institute for Civil Justice [hyperlink] and the RAND Kenneth R. Feinberg Center for Catastrophic Risk Management and Compensation [hyperlink] convened a virtual event to discuss (1) the challenges in facilitating the global distribution of COVID-19 vaccines and (2) how to prevent liability and compensation concerns from affecting the vaccine supply chain and the uptake of the vaccine by the public." The duration of this video is 1 hour, 32 minutes, and 41 seconds.

Author:
Publisher:
Date:
2020-12-22
Series:
Copyright:
RAND Corporation
Retrieved From:
RAND Corporation: http://www.rand.org/
Media Type:
text/html
URL:
Help with citations